Rhealba® oat plantlet extract: Evidence of protein-free content and assessment of regulatory activity on immune inflammatory mediators

Planta Medica

Volumn 77, Issue 9, 2011, Pages 900-906

  Mandeau, Anne ^a   Aries, Marie Françoise ^b   Boé, Jean François ^a   Brenk, Manuela ^c   Crebassa Trigueros, Véronique ^a   Vaissière, Clémence ^b   Teysseyre, Valérie ^a   Bieber, Thomas ^c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

atopic dermatitis; Avena sativa L.; immune response; inflammation; oat plantlet; Poaceae

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; AVENACOSID A; AVENACOSID B; FLAVONOID; INTERLEUKIN 2; ISOORIENTIN 2'' O ARABINOSIDE; ISOVITEXIN 2'' O ARABINOSIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RHEALBA; SAPONIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; OAT; PHENOTYPE; PLANTLET; T LYMPHOCYTE; WESTERN BLOTTING;

6-KETOPROSTAGLANDIN F1 ALPHA; ANTI-INFLAMMATORY AGENTS; AVENA SATIVA; CELL PROLIFERATION; DENDRITIC CELLS; EPOPROSTENOL; FLAVONOIDS; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2; KERATINOCYTES; PHENOTYPE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SAPONINS; T-LYMPHOCYTES;

AVENA SATIVA; POACEAE;

EID: 79958785510     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250649     Document Type: Article

References (19)

1. European Medicines Agency. Evaluation of Medicines for Human Use. Assessment report on Avena sativa L., Herba and Avena sativa L., Fructus. EMEA/HMPC/202967/2007; 2008. Available at http://www.emea.europa.eu/pdfs/human/ hmpc/avena-fructus/20296707en.pdf. Accessed July 28, 2010
2. Blumenthal M, Goldberg A, Brinkmann J. Herbal Medicine: Expanded Commission E Monographs. Austin: American Botanical Council; Boston (MA): Integrative Medicine Communications; 2000
3. Volak J, Stodola J. [Plantes médicinales. 256 illustrations en couleurs]. Paris: Gründ; 1983: 90
4. European Medicines Agency. Evaluation of Medicines for Human Use. Community herbal monograph on Avena sativa L., herba. EMEA/HMPC/202966/2007; 2008. Available at http://www.emea.europa.eu/pdfs/human/hmpc/avena-herba/ 20296607enfin.pdf. Accessed July 28, 2010
5. Popovici G, Weissenboeck G, Bouillant ML, Dellamonica G, Chopin J. Isolation and characterization of flavonoids from Avena sativa L. Z Pflanzenphysiol 1977; 85: 103-115
6. Chopin J, Dellamonica G, Bouillant ML, Besset A, Popovici G,Weissenböck G. C-Glycosylflavones from Avena sativa. Phytochemistry 1977; 16: 2041-2043
7. Wenzig E, Kunert O, Ferreira D, Schmid M, Schühly W, Bauer R, Bauer R, Hiermann A. Flavonolignans from Avena sativa. J Nat Prod 2005; 68: 289-292 (Pubitemid 40299828)
8. Osbourn AE. Preformed antimicrobial compounds and plant defense against fungal attack. Plant Cell 1996; 8: 1821-1831 (Pubitemid 27012407)
9. Middleton Jr E. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998; 439: 175-182 (Pubitemid 28429016)
10. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494
11. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112: S128-S139 (Pubitemid 37550029)
12. Mimaki Y, Nakamura Y, Nikaido T, Ohmoto T. Steroidal saponins from the bulbs of Triteleia lacteal and their inhibitory activity on cyclic AMP phosphodiesterase. Phytochemistry 1995; 38: 1279-1286
13. Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-124 (Pubitemid 15103513)
14. Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, Naito M, Takahashi K. Generation of CD1 + RelB + dendritic cells and tartrateresistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996; 88: 4029-4039 (Pubitemid 26383128)
15. Kraft S,Wessendorf JH, Hanau D, Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998; 161: 1000-1006 (Pubitemid 28323568)
16. Tschesche R, Tauscher M, Fehlhaber HW, Wulff G. Avenacosid A, ein bisdesmosidisches Steroidsaponin aus Avena sativa. Chem Ber 1969; 102: 2072-2082
17. Tschesche R, Lauven P. Avenacosid B, ein zweites bisdesmosidisches Steroidsaponin aus Avena sativa. Chem Ber 1971; 104: 3549-3555
18. Aries M, Vaissiere C, Charveron M, Castex-Rizzi N. Avena sativa aerial part extract regulates skin immunoinflammatory disorders as atopic dermatitis pathology. 39th Annual Meeting of the European Society of Dermatological Research (ESDR), 10 September 2009, Budapest, Hungary. J Invest Dermatol 2009; 129 (Suppl. 2): S4 (Abstract 020)
19. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125 (Pubitemid 23068296)